Agilent Q2 Revenues Slide 3 Percent | GenomeWeb

NEW YORK(GenomeWeb) – Agilent Technologies reported after the close of the market on Monday that its fiscal second quarter revenues were down almost 3 percent year over year. 

For the three months ended April 30, the firm reported $963 million in revenues, down from $988 million in Q2 2014, and missing the average analysts' estimate of $983.9 million. Excluding currency effects, revenues were up 4 percent year over year, Agilent said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.